Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) Net Income towards Common Stockholders (2016 - 2025)

MedWellAI (MWAI) has disclosed Net Income towards Common Stockholders for 11 consecutive years, with -$287519.0 as the latest value for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders rose 57.34% to -$287519.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.7 million, a 34.36% increase, with the full-year FY2025 number at -$3.6 million, up 69.97% from a year prior.
  • Net Income towards Common Stockholders was -$287519.0 for Q4 2025 at MedWellAI, up from -$651878.0 in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $1.2 million in Q3 2021 to a low of -$22.3 million in Q2 2023.
  • A 5-year average of -$3.4 million and a median of -$1.1 million in 2022 define the central range for Net Income towards Common Stockholders.
  • Biggest YoY gain for Net Income towards Common Stockholders was 412.76% in 2021; the steepest drop was 3630.14% in 2021.
  • MedWellAI's Net Income towards Common Stockholders stood at -$650774.0 in 2021, then crashed by 114.5% to -$1.4 million in 2022, then surged by 59.35% to -$567360.0 in 2023, then fell by 18.78% to -$673911.0 in 2024, then skyrocketed by 57.34% to -$287519.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Net Income towards Common Stockholders are -$287519.0 (Q4 2025), -$651878.0 (Q3 2025), and -$1.1 million (Q2 2025).